U.S. IV Infusion Products Market

The administration of drugs via a needle or catheter is known as infusion treatment. Infusion therapy refers to administration of a medicine intravenously or subcutaneously. A medical device that consists of a thin tube attached to a pump is known as an infusion catheter. A cavity, duct, or vessels in the body holds the thin tube. Infusion catheters are frequently implanted in chemotherapy patients to get reliable intravenous access. Market Dynamics Market players are focused on product launches or approvals, which is expected to drive growth of the U.S. IV infusion products market over the forecast period. For instance, on February 8, 2016, AngioDynamics Inc., a provider of medical devices, received approval from the Health Canada for its Celerity PICC Tip Confirmation System developed for the positioning of peripherally inserted central catheters (PICC) in adult patients. Celerity with navigation adds real-time catheter tracking to the prior version of the tip localization system, allowing doctors to view the location of the PICC tip at all times and improving the clinician experience. U.S. IV infusion product market is estimated to witness significant growth, owing to various reimbursement scenarios for infusion products in the U.S. For instance, according to the Center for Medicare & Medicaid Services (CMS), the following products are available for reimbursement: Code Product Description E0776 IV POLE E0779 Ambulatory infusion pump, mechanical, reusable for infusion of 8 hours or greater E0780 Ambulatory infusion pump, mechanical, reusable for infusion less than 8 hours E0781 Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient E0784 External ambulatory infusion pump Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, and this is expected to drive growth of the U.S. IV infusion products market. For instance, on August 21, 2019, B. Braun Medical Inc. and Steward Health Care, a private, physician-led health care network in the U.S., entered into a seven year agreement to purchase IV solutions and Infusomat and Perfusor space pumps. As part of this long-term agreement, Steward Health Care will install over 5,000 Infusomat and Perfusor cordless space pumps in its 36 domestic hospitals and outpatient facilities. Key features of the study • This report provides an in-depth analysis of S. IV infusion products market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year. • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players • It profiles leading players in the U.S. IV infusion products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans • Key companies covered as a part of this study include AngioDynamics Inc., Kimal, Terumo Corporation, Teleflex Inc., Becton Dickinson and Company, Cook Group, Nipro Corporation, ZOLL Medical Corporation, B. Braun Medical Inc., AdvaCare Pharma, PL Medical Co. LLC, Greiner Bio-One International GmbH, EMED Technologies Corporation, CODAN Companies, and Smiths Group plc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics • The U.S. IV infusion products market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. IV infusion products market. Market Segmentation • By Product Type Insights (Revenue, USD Mn, 2021 - 2033) o Cannulation  Needles  Catheter o IV Infusion Pump  Gravity Infusion Devices  Volumetric Pump  Syringe Pump  Others o Infusion Lines (Set)  Gravity IV Set  Gravity IV Set W/Needle Free Connector  Pump IV Set o Others • By Stop Cock Type Insights (Revenue, USD Mn, 2021 - 2033) o 3 Way Stopcock o Vacuum Stopcocks o Burette Stopcocks o Others • By Needle Free Connector Insights (Revenue, USD Mn, 2021 - 2033) o Standalone Connectors o Needle-free Extension Sets • By Infusion Site Insights (Revenue, USD Mn, 2021 - 2033) o Peripheral IV o Medline IV o Central IV • By Application Insights (Revenue, USD Mn, 2021 - 2033) o Pain Management o Antibiotic/Antiviral o Chemotherapy o Others • By End User Insights (Revenue, USD Mn, 2021 - 2033) o Ambulatory Surgical Centers o Clinics o Home Care Settings o Hospitals o Others • Key Players in the U.S. IV Infusion Products Market o AngioDynamics Inc. o Kimal o Terumo Corporation o Teleflex Inc. o Becton Dickinson and Company o Cook Group o Nipro Corporation o ZOLL Medical Corporation o Braun Medical Inc. o AdvaCare Pharma o PL Medical Co. LLC o Greiner Bio-One International GmbH o EMED Technologies Corporation o CODAN Companies o Smiths Group plc.